149 related articles for article (PubMed ID: 16904448)
1. Prostatic tissue testosterone and dihydrotestosterone in African-American and white men.
Marks LS; Hess DL; Dorey FJ; Macairan ML
Urology; 2006 Aug; 68(2):337-41. PubMed ID: 16904448
[TBL] [Abstract][Full Text] [Related]
2. Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens.
Marks LS; Hess DL; Dorey FJ; Luz Macairan M; Cruz Santos PB; Tyler VE
Urology; 2001 May; 57(5):999-1005. PubMed ID: 11337315
[TBL] [Abstract][Full Text] [Related]
3. Serum testosterone levels in African-American and white men undergoing prostate biopsy.
Kubricht WS; Williams BJ; Whatley T; Pinckard P; Eastham JA
Urology; 1999 Dec; 54(6):1035-8. PubMed ID: 10604704
[TBL] [Abstract][Full Text] [Related]
4. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada.
Wu AH; Whittemore AS; Kolonel LN; John EM; Gallagher RP; West DW; Hankin J; Teh CZ; Dreon DM; Paffenbarger RS
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):735-41. PubMed ID: 8672990
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Habib FK; Ross M; Tate R; Chisholm GD
Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
[TBL] [Abstract][Full Text] [Related]
6. Testosterone and dihydrotestosterone levels in the transition zone correlate with prostate volume.
Pejčić T; Tosti T; Tešić Ž; Milković B; Dragičević D; Kozomara M; Čekerevac M; Džamić Z
Prostate; 2017 Jul; 77(10):1082-1092. PubMed ID: 28594074
[TBL] [Abstract][Full Text] [Related]
7. Androgen concentrations in expressed prostatic secretions: no correlation with tissue levels.
Habib FK; Goodman CM; Buck C
Urol Res; 1992; 20(4):281-4. PubMed ID: 1380746
[TBL] [Abstract][Full Text] [Related]
8. Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer.
Titus MA; Schell MJ; Lih FB; Tomer KB; Mohler JL
Clin Cancer Res; 2005 Jul; 11(13):4653-7. PubMed ID: 16000557
[TBL] [Abstract][Full Text] [Related]
9. Serum androgen levels in black, Hispanic, and white men.
Litman HJ; Bhasin S; Link CL; Araujo AB; McKinlay JB
J Clin Endocrinol Metab; 2006 Nov; 91(11):4326-34. PubMed ID: 16912139
[TBL] [Abstract][Full Text] [Related]
10. High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients.
Miyoshi Y; Uemura H; Umemoto S; Sakamaki K; Morita S; Suzuki K; Shibata Y; Masumori N; Ichikawa T; Mizokami A; Sugimura Y; Nonomura N; Sakai H; Honma S; Harada M; Kubota Y
BMC Cancer; 2014 Sep; 14():717. PubMed ID: 25256077
[TBL] [Abstract][Full Text] [Related]
11. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer.
Rittmaster R; Hahn RG; Ray P; Shannon JB; Wurzel R
Urology; 2008 Oct; 72(4):808-12. PubMed ID: 18718641
[TBL] [Abstract][Full Text] [Related]
12. High serum dihydrotestosterone examined by ultrasensitive LC-MS/MS as a predictor of benign prostatic hyperplasia or Gleason score 6 cancer in men with prostate-specific antigen levels of 3-10 ng/mL.
Miyoshi Y; Uemura H; Suzuki K; Shibata Y; Honma S; Harada M; Kubota Y
Andrology; 2017 Mar; 5(2):262-267. PubMed ID: 27813361
[TBL] [Abstract][Full Text] [Related]
13. Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content.
Forti G; Salerno R; Moneti G; Zoppi S; Fiorelli G; Marinoni T; Natali A; Costantini A; Serio M; Martini L
J Clin Endocrinol Metab; 1989 Feb; 68(2):461-8. PubMed ID: 2465302
[TBL] [Abstract][Full Text] [Related]
14. [Endogenous androgen levels of human prostatic tissues].
Morioka M; Takeda K; Mitsuhata N; Ohashi T; Ohmori H; Saito T; Kanbegawa A
Nihon Naibunpi Gakkai Zasshi; 1982 Jul; 58(7):876-85. PubMed ID: 6182032
[TBL] [Abstract][Full Text] [Related]
15. Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: unique importance of extratesticular androgens in men.
Bélanger B; Bélanger A; Labrie F; Dupont A; Cusan L; Monfette G
J Steroid Biochem; 1989 May; 32(5):695-8. PubMed ID: 2525654
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen and androgens in African-American and white normal subjects and prostate cancer patients.
Asbell SO; Raimane KC; Montesano AT; Zeitzer KL; Asbell MD; Vijayakumar S
J Natl Med Assoc; 2000 Sep; 92(9):445-9. PubMed ID: 11052458
[TBL] [Abstract][Full Text] [Related]
17. Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial.
Muller RL; Gerber L; Moreira DM; Andriole G; Castro-Santamaria R; Freedland SJ
Eur Urol; 2012 Nov; 62(5):757-64. PubMed ID: 22658758
[TBL] [Abstract][Full Text] [Related]
18. Racial differences in prostate androgen levels in men with clinically localized prostate cancer.
Mohler JL; Gaston KE; Moore DT; Schell MJ; Cohen BL; Weaver C; Petrusz P
J Urol; 2004 Jun; 171(6 Pt 1):2277-80. PubMed ID: 15126802
[TBL] [Abstract][Full Text] [Related]
19. Concentration of the endogenous antiandrogen epitestosterone and androgenic C19-steroids in hyperplastic prostatic tissue.
Hill M; Hampl R; Petrík R; Stárka L
Prostate; 1996 Jun; 28(6):347-51. PubMed ID: 8650070
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and biopsy specimen features in African-American and white men without prostate cancer.
Eastham JA; May RA; Whatley T; Crow A; Venable DD; Sartor O
J Natl Cancer Inst; 1998 May; 90(10):756-60. PubMed ID: 9605645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
